3 No-Brainer Dividend Stocks to Buy in September
Ownership has its privileges -- at least with many stocks. More than 5,000 stocks that trade on U.S. exchanges return a portion of their profits to shareholders as dividends. Not all of them are great picks to buy right now, but some are.
Three Fool.com contributors were asked to recommend some no-brainer dividend stocks to buy in September. They selected healthcare companies (NYSE: ABBV), Merck (NYSE: MRK), and Pfizer (NYSE: PFE). Here's why.
Keith Speights (AbbVie): You can count the number of Dividend Kings that operate in the healthcare sector on one hand and have a thumb left over. AbbVie is one of the four. The big pharmaceutical company has increased its dividend annually for 52 consecutive years.
Source Fool.com
AbbVie Inc. Stock
€175.30
0.030%
The stock is an absolute favorite of our community with 34 Buy predictions and no Sell predictions.
As a result the target price of 180 € shows a slightly positive potential of 2.68% compared to the current price of 175.3 € for AbbVie Inc..
